Cancer Research and Clinic 2006 Issue 7 zhong xi yi jie he zhi liao wei ai gan fei zhuan yi yi li

zhong xi yi jie he zhi liao wei ai gan fei zhuan yi yi li
chen yan zhi ; li ping ping ; yang hua

..............page:504-504

zhi chang gang guan ai de fang she zhi liao
fan zuo ; wu yong jia ; fan hong yan

..............page:501-503

zuo men shi chi huan zheng bing fa shi guan ai yi li
guo shi ping ; zheng kang

..............page:491-491

Caveolae and multidrug resistance of tumor cells
WANG Rui-hua;SHI Yong-quan

..............page:498-500

Research about the indexes to assess the biological behavior of the giant cell tumor of bone
FENG Yi;LU Zhi

..............page:495-498

The role mechanism of alpha fetoprotein in escaping immune surveillance of hepatoma cells
LI Meng-sen;LI Gang

..............page:492-495

zu zhi zhong bo de shi mo lu yuan zi xi shou fa ce ding
huang ping ; li yan ; zhou li ; zhu an na ; xu man man ; li cong zhu ; zhang yuan

..............page:490-491

pAdKDR-tk and pAdCMV suicide gene system cytotoxicity and specificity in vitro
QIU Qian-hui;LI Tian-ying;CHEN Shao-hua;ZHANG Si-yi

..............page:445-447

Study of using α-cyanoacrylate to establish the orthotopic transplantation tumor model from the subcutaneous model of human hepatocellular carcinoma in nude mice
BAI Jun-wen;YANG Cheng-wang;SU Bing-zhong;SU Xiu-lan

..............page:442-444

Progress in the treatment of metastatic renal cell carcinoma
XIE Li-ping;MAO Qi-qi

..............page:433-436

Study the anti-tumor effect and its mechanism of arsenic trioxide combined with fluorouracil on human large intestine carcinoma cell
LIU Lin;ZHAO Wei;QIN Shu-kui;LI Su-yi;QIU Shao-min;CHEN Hui-ying

..............page:437-441

fu zuo li duo yu ang dan si qiong yu fang fu ke zhong liu kai fu qie chu shu hou e xin ou tu de lin chuang guan cha
ma zeng yan

..............page:488-489

zi shan chun lian he shun bo zhi liao wan qi bi yan ai lin chuang ying yong
huang jian heng ; li yi gang ; lai su zhen ; liu dan zuo

..............page:487-488

jie ru hua liao hou wai ke zhi liao qi zuo men ai 76 li
zhang rong sheng ; liu fu cai ; yue qiang

..............page:485-487

e xing zhong liu ji fa xing xue xiao ban zeng duo zheng si li
kong li hui ; wu yan ping

..............page:484-485

ji xi ta bin lian he shun bo zhi liao wan qi fei xiao xi bao fei ai 48 li
gan ning ; chen huan chao

..............page:483-484

can zuo fu zheng zhu she ye zhi liao e xing zhong liu huan zhe duo han de lin chuang guan cha
li wei bing

..............page:482-483

zhi chang ai shu hou ju bu fu fa 40 li lin chuang fen xi
liu ji bao ; zhou yong ; qi pan

..............page:481-482

np yu ep fang an zhi liao fei xiao xi bao fei ai liao xiao guan cha
yao yi bo ; dong bing chao

..............page:479-480

guo chan zhong zu ren bai xi bao jie su -11 zhi liao xue xiao ban jian shao de lin chuang yan jiu
gao da quan ; qian shen xian ; shi peng fei ; tan jun feng ; liu li rong ; chen kuang ; huang xi lian

..............page:478-479

fu qiang jing zhi chang ai gen zhi shu 8 li
li sheng

..............page:476-477

ru xian ai liang zhou fang an xin fu zhu hua liao lin chuang yan jiu
jia guo cong ; song zai

..............page:475-476

xiao hua xi tong e xing zhong liu gan zhuan yi san wei shi xing fang liao de lin chuang guan cha
li wei lu ; wang chuan li

..............page:473-474

xiong da ji ji pi ban zai tou jing bu shou shu que sun xiu fu zhong de ying yong
nan jie ; mi yu lu

..............page:472-473

A clinical study on treating intractable ovarian cancer with Xiao'aiping-SSA
PEI Yi;WEI Shu-qing;YANG Yong-ming;HAN Lin;YU Jing;LI Qi;REN Xiao-hui;LI Ai-ping;MA Xiao-jun;XIE Li;WANG Rong

..............page:469-471

Bleomycin combined with Interleukin-2 in the treatment of patients with malignant pleural effusion from NSCLC
HE Mei

..............page:467-468

Comparative investigation of three trentments in regionally-advanced nasopharyngeal carcinoma
MA Dai-yuan;WANG Ren-sheng;LI Xiang-pan

..............page:464-466

The observation of clinical efficacy of rituximab in combination with DHAP chemotherapy in patients with relapsed non-hodgkin lymphoma
WEN Ji-yu;XIE Zhong;XIE Jie-rong

..............page:462-463

Clinic research of oxaliplatin combined with HLF for patients with advanced gastric cancer
ZHENG Lei-zhen;SHEN Wei;ZHANG Li;GU Wen-hua;LI Xiao-ping;CHEN Si-yu;WANG Bei-li;WANG Li-na;GU Jian-chun;CHEN Qiang

..............page:459-461

The research of γδT cells from patients with esophageal squamous carcinoma
WANG Chun-li;ZHANG Shao-yun;MA Yan-yan;ZHANG Su-ying;GUO Shi-ping;ZHANG Shuang-ping;LIAN Jian-hong

..............page:456-458,461

The immuohistochemical investigation of mucose amelanotic malignant melanoma
WANG Li-xia;MI Zhe-tao;YIN Wei-dong;WANG Quan-hong;WANG Jin-fen

..............page:453-455

Antiangiogenesis effect study of anticancer active fraction for two kinds of chinese herbal medicine
TUO Ya;SU Xiu-lan;KE Yang

..............page:451-452,455

siRNA-2 can enhance the drug-sensitivity of HL-60 cells to homoharringtonin
HU Hai-yan;ZHANG Yuan;LI Ping;XU Meng

..............page:448-450